| Stage | ISRG | % of rev | ALGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.0B | 100.00% | $1.0B | 100.00% | ISRG ×3.00 |
| Gross profit | $2.1B | 68.37% | $697M | 68.73% | ALGN +0.4pp |
| Operating income | $593M | 19.44% | $169M | 16.67% | ISRG +2.8pp |
| Pre-tax income | $668M | 21.92% | $170M | 16.76% | ISRG +5.2pp |
| Net income | $524M | 17.20% | $135M | 13.31% | ISRG +3.9pp |
| Stage | ISRG | ALGN | Gap · A − B |
|---|---|---|---|
| Revenue | $3.0B100.00% | $1.0B100.00% | ISRG ×3.00 |
| Gross profit | 68.37%$2.1B | 68.73%$697M | ALGN +0.4pp |
| Operating income | 19.44%$593M | 16.67%$169M | ISRG +2.8pp |
| Pre-tax income | 21.92%$668M | 16.76%$170M | ISRG +5.2pp |
| Net income |
| 17.20%$524M |
| 13.31%$135M |
| ISRG +3.9pp |